Clinical trial

High Potency Statins and the Risk of Diabetes

NCT02518503

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-07-01

PhaseN/A

Study timeline

Study start (unknown)2012-07-01Date precision: month

Registry last updated2016-03-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Cardiovascular Diseaseunresolved

Interventions

Rosuvastatin (≥10 mg)DRUG

Atorvastatin (≥20 mg)DRUG

Simvastatin (≥40 mg)DRUG

FluvastatinDRUG · verified · RxNorm: fluvastatin

PravastatinDRUG · verified · RxNorm: pravastatin

LovastatinDRUG · verified · RxNorm: lovastatin

Rosuvastatin (<10mg)DRUG

Atorvastatin (<20mg)DRUG

Simvastatin (<40 mg)DRUG

Sponsors & collaborators

Canadian Network for Observational Drug Effect Studies, CNODESlead sponsor

Drug Safety and Effectiveness Network, Canadacollaborator

Canadian Institutes of Health Research (CIHR)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02518503 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.